Large-volume-apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients

Journal of Clinical Apheresis

Volumn 24, Issue 1, 2009, Pages 12-17

  Majado, Maria Juliana ^a   Minguela, Alfredo ^a   González García, Consuelo ^a   Salido, Eduardo ^a   Blanquer, Miguel ^a   Funes, Consuelo ^a   Insausti, Carmen Luisa ^a   García Hernández, Ana Maria ^a   Moraleda, José María ^a   Morales, Alfonso ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Large volume apheresis; PBPCS apheresis; Poor mobilizer patients

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; APHERESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD VOLUME; BREAST CANCER; CD34 SELECTION; CELL VOLUME; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LARGE VOLUME APHERESIS; LEUKEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; SEX DIFFERENCE; STEM CELL MOBILIZATION; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63249086843     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20191     Document Type: Article

References (39)

1. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 2005;20:349-356.
2. Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006;34:967-975.
3. Taichman RS. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 2005;105:2631-2639.
4. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-694.
5. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-3969.
6. Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, Champlin RE, Körbling M. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 1999;39:555-560.
7. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992;339:640-644.
8. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996;347:353-357.
9. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723-727.
10. Perry AR, Peniket AJ, Watts MJ, Leverett D, Goldstone AH, Linch DC. Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis. Br J Haematol 1999;105:280-287.
11. Siena S, Bregni M, Gianni AM. Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and GCSF or GM-CSF. Baillieres Best Pract Res Clin Haematol 1999;12:27-39.
12. Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD, Vesole DH, Badel K, Calandra G. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005;106: 1867-1874.
13. Körbling M. Collection of allogeneic peripheral blood stem cells. Baillieres Best Pract Res Clin Haematol 1999;12:41-55.
14. Watts MJ, Ings SJ, Leverett D, MacMillan A, Devereux S, Goldstone AH, Linch DC. ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m-2 and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients. Br J Cancer 2000;82: 278-282.
15. Hicks ML, Lonial S, Langston A, Flowers C, Roback JD, Smith KJ, Mossavi Sai S, Teagarden D, Hamilton ES, Waller EK, Kaufman J. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion 2007;47:629-635.
16. Nosari A, Cairoli R, Ciapanna D, Gargantini L, Intropido L, Baratae C, Scarpati B, Santoleri L, Nador G, Pezzetti L, Morra E. Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens. Bone Marrow Transplant 2006;38:413-416.
17. Hill QA, Buxton D, Pearce R, Gesinde MO, Smith GM, Cook G. An analysis of the optimal timing of peripheral blood stem cell harvesting following priming with cyclophosphamide and G-CSF. Bone Marrow Transplant 2007;40:925-930.
18. Stiff PJ. Management strategies for the hard-to-mobilize patient. Bone Marrow Transplant 1999;23:S29-S33.
19. D'Arena G, Musto P, Di Mauro L, Cascavilla N, Iacono ND, Scalzulli PR, Matera R, Carotenuto M. Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies. Am J Hematol 1998;58:255-262.
20. Perea G, Sureda A, Martino R, Altés A, Martínez C, Cabezudo E, Amill B, Martín-Henao GA, González Y, Muñoz L, Peyret M, Brunet S, Sierra J. Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma. Ann Hematol 2001;80:592-597.
21. Movassaghi K, Jaques G, Schmitt-Thomssen A, Fischer EG, Paulus M, Heuft HG, Schwella N. Evaluation of the COM.TEC cell separator in predicting the yield of harvested CD34+ cells. Transfusion 2007;47:824-831.
22. Lefrère F, Zohar S, Beaudier S, Audat F, Ribeil JA, Ghez D, Varet B, Cavazzana-Calvo M, Dal Cortivo L, Letestu R, McIntyre E, Brouzes C. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis. Transfusion 2007;47:1851-1857.
23. Noga SJ, Vogelsang GB, Miller SC, Meusel S, Loper K, Case R, Myers B, Rogers L, Flinn I, Borowitz M, O'Donnell P. Using point-of-care CD34 enumeration to optimize PBSC collection conditions. Cytotherapy 2001;3:11-18.
24. Perry AR, Watts MJ, Peniket AJ, Goldstone AH, Linch DC. Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy. Bone Marrow Transplant 1998;21:1201-1205.
25. Fu P, Bagai RK, Meyerson H, Kane D, Fox RM, Creger RJ, Cooper BW, Gerson SL, Laughlin MJ, Koc ON, Lazarus HM. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization. Bone Marrow Transplant 2006;38:189-196.
26. Watts MJ, Ings SJ, Flynn M, Dodds D, Goldstone AH, Linch DC. Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile. Br J Haematology 2000;111:287-291.
27. Meehan KR, Hill JM, Patchett L, Webber SM, Wu J, Ely P, Szczepiorkowski ZM. Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization. Transfusion 2006;46:523-529.
28. Trickett AE, Smith S, Kwan YL. Accurate calculation of blood volume to be processed by apheresis to achieve target CD34+ cell numbers for PBPC transplantation. Cytotherapy 2001;3: 5-10.
29. Lie AK, Rawling TP, Bayly JL, To LB. Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of haemopoietic growth factor and chemotherapy. Br J Haematol 1996;95:39-44.
30. Bojko P, Scharifi M, Stössel K, Seeber S. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38- and CD34+49d+ subsets during apheresis. J Cancer Res Clin Oncol 2002;128:19-28.
31. Fontana S, Groebli R, Leibundgut K, Pabst T, Zwicky C, Taleghani BM. Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency. Transfusion 2006;46: 1408-1416.
32. Moller AK, Dickmeiss E, Geisler CH, Christensen LD. Recruitment of CD34+ cells during large-volume leukapheresis. J Hematother Stem Cell Res 2001;10:837-853.
33. Cassens U, Ostkamp-Ostermann P, van der Werf N, Garritsen H, Ostermann H, Sibrowski W. Volume-dependent collection of peripheral blood progenitor cells during large-volume leukapheresis for patients with solid tumours and haematological malignancies. Transfus Med 1999;9:311-320.
34. Desikan KR, Jagannath S, Siegel D, Nelson J, Bracy D, Barlogie B, Tricot G. Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma. Leuk Lymphoma 1998;28:501-508.
35. Watts MJ, Sullivan AM, Leverett D, Peniket AJ, Perry AR, Williams CD, Devereux S, Goldstone AH, Linch DC. Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization. J Clin Oncol 1998;16: 1554-1560.
36. Murea S, Goldschmidt H, Hahn U, Pförsich M, Moos M, Haas R. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses. J Clin Apher 1996;11:185-194.
37. Malachowski ME, Comenzo RL, Hillyer CD, Tiegerman KO, Berkman EM. Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 1992;32:732-735.
38. Humpe A, Riggert J, Munzel U, Köhler M. A prospective, randomized, sequential crossover trial of large-volume versus normal-volume leukapheresis procedures: effects on serum electrolytes, platelet counts, and other coagulation measures. Transfusion 2000;40:368-374.
39. Smolowicz AG, Villman K, Tidefelt U. Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion 1997;37:188-192.